6 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp02172 | C7A | KILRGVAKKIMRTFLRRISKDILTGKK | NK-2 peptide based derivatives | Apoptosis; Necrosis | Cell viability assay | HROC32 | Colorectal cancer | Cell viability : >60% at 25μM approx. |
| dbacp02179 | C7A | KILRGVAKKIMRTFLRRISKDILTGKK | NK-2 peptide based derivatives | Apoptosis; Necrosis | Cell viability assay | HROC32 | Colorectal cancer | Cell viability : >55% at 12.5μM approx. |
| dbacp02193 | C7A-D21K | KILRGVAKKIMRTFLRRISKKILTGKK | NK-2 peptide based derivatives | Apoptosis; Necrosis | Cell viability assay | HROC32 | Colorectal cancer | Cell viability : 50% at 12.5μM approx. |
| dbacp02200 | C7A-D21K | KILRGVAKKIMRTFLRRISKKILTGKK | NK-2 peptide based derivatives | Apoptosis; Necrosis | Cell viability assay | HROC32 | Colorectal cancer | Cell viability : >80% at 12.5μM approx. |
| dbacp02213 | C7A-Δ | KILRGVAKKIMRTFLRRISKDILTGKK | NK-2 peptide based derivatives | Apoptosis; Necrosis | Cell viability assay | HROC32 | Colorectal cancer | Cell viability : 50% at 12.5μM approx. |
| dbacp02220 | C7A-Δ | KILRGVAKKIMRTFLRRISKDILTGKK | NK-2 peptide based derivatives | Apoptosis; Necrosis | Cell viability assay | HROC32 | Colorectal cancer | Cell viability : >85% at 12.5μM approx. |